JP2012025767A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012025767A5 JP2012025767A5 JP2011215077A JP2011215077A JP2012025767A5 JP 2012025767 A5 JP2012025767 A5 JP 2012025767A5 JP 2011215077 A JP2011215077 A JP 2011215077A JP 2011215077 A JP2011215077 A JP 2011215077A JP 2012025767 A5 JP2012025767 A5 JP 2012025767A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- independently hydrogen
- cancer cell
- alkylhalo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48288603P | 2003-06-25 | 2003-06-25 | |
| US60/482,886 | 2003-06-25 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006517702A Division JP2007524633A (ja) | 2003-06-25 | 2004-06-25 | 癌細胞におけるアポトーシスの誘導のための化合物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012025767A JP2012025767A (ja) | 2012-02-09 |
| JP2012025767A5 true JP2012025767A5 (https=) | 2013-01-10 |
Family
ID=34102647
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006517702A Pending JP2007524633A (ja) | 2003-06-25 | 2004-06-25 | 癌細胞におけるアポトーシスの誘導のための化合物および方法 |
| JP2011215077A Pending JP2012025767A (ja) | 2003-06-25 | 2011-09-29 | 癌細胞におけるアポトーシスの誘導のための化合物および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006517702A Pending JP2007524633A (ja) | 2003-06-25 | 2004-06-25 | 癌細胞におけるアポトーシスの誘導のための化合物および方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US7812058B2 (https=) |
| EP (2) | EP1938816B1 (https=) |
| JP (2) | JP2007524633A (https=) |
| AT (2) | ATE478663T1 (https=) |
| AU (1) | AU2004258867B2 (https=) |
| CA (1) | CA2529507C (https=) |
| DE (2) | DE602004012279T3 (https=) |
| DK (1) | DK1653943T4 (https=) |
| ES (2) | ES2351581T3 (https=) |
| PL (1) | PL1653943T6 (https=) |
| PT (1) | PT1653943E (https=) |
| SI (1) | SI1653943T1 (https=) |
| WO (1) | WO2005009434A2 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7432304B2 (en) * | 2001-05-30 | 2008-10-07 | The Regents Of The University Of Michigan | Small molecule antagonists of Bcl-2 family proteins |
| AU2002360335A1 (en) * | 2001-11-01 | 2003-05-12 | The Regents Of The University Of Michigan | Small molecule inhibitors targeted at bcl-2 |
| DE602004012279T3 (de) | 2003-06-25 | 2010-07-15 | The Burnham Institute, La Jolla | Katecholderivate zur behandlung von krebs |
| EA011218B1 (ru) | 2004-03-25 | 2009-02-27 | Дзе Риджентс Оф Дзе Юниверсити Оф Мичиган | Сокристаллы госсипола и их применение |
| US20060144723A1 (en) * | 2004-11-02 | 2006-07-06 | Mary Fuller | Device for securing valuables |
| WO2009045410A1 (en) * | 2007-10-01 | 2009-04-09 | Ascenta Therapeutics, Inc. | Process for preparing r-gossypol l-phenylalaninol dienamine |
| AU2008311827A1 (en) * | 2007-10-19 | 2009-04-23 | Burnham Institute For Medical Research | Naphthalene-based inhibitors of anti-apoptotic proteins |
| FR2924712B1 (fr) | 2007-12-06 | 2012-12-21 | Univ Maine | Derives du gossypol et de l'apogossypol, leurs preparations et leurs applications |
| GB0725077D0 (en) * | 2007-12-21 | 2008-01-30 | Univ Murcia | Antifolate com[ounds for the treatment of melanoma |
| WO2009126172A1 (en) * | 2008-04-11 | 2009-10-15 | The Trustees Of Columbia University In The City Of New York | Resistance to polyphenon e due to increased bcl-2 expression |
| US20110144125A1 (en) * | 2008-08-14 | 2011-06-16 | The Uab Research Foundation | Anti-Arrhythmia Agents, Methods of Their Use, Methods of Their Identification and Kits Therefore |
| US8487131B2 (en) | 2009-04-15 | 2013-07-16 | Sanford-Burnham Medical Research Institute | Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2) |
| BRPI1016102A2 (pt) | 2009-04-15 | 2015-09-01 | Sanford Burhnham Medical Res Inst | Inibidores de proteínas anti-apoptótica baseados em naftaleno |
| WO2011017096A2 (en) * | 2009-08-04 | 2011-02-10 | Mayo Foundation For Medical Education And Research | Methods of treating hematologic cancers |
| KR20120060234A (ko) | 2009-10-08 | 2012-06-11 | 샌포드-번햄 메디칼 리서치 인스티튜트 | 항암제로서의 아포고시폴론 유도체 |
| EP2956470A4 (en) * | 2013-02-15 | 2016-12-07 | Univ Michigan Regents | COMPOSITIONS AND METHODS RELATED TO PREVENTING DOT1L RECRUITMENT BY MLL FUSION PROTEINS |
| US9655998B2 (en) | 2014-08-07 | 2017-05-23 | Cook Medical Technologies Llc | Encapsulated drug compositions and methods of use thereof |
| US11241520B2 (en) | 2014-08-07 | 2022-02-08 | Cook Medical Technologies Llc | Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof |
| US9180226B1 (en) | 2014-08-07 | 2015-11-10 | Cook Medical Technologies Llc | Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof |
| US10195213B2 (en) | 2015-03-13 | 2019-02-05 | Unity Biotechnology, Inc. | Chemical entities that kill senescent cells for use in treating age-related disease |
| US9750716B2 (en) * | 2015-03-19 | 2017-09-05 | Wendy Anne Epstein | Compounds and forms of treatment for female sexual disorders |
| RU2654711C1 (ru) * | 2017-07-10 | 2018-05-22 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) | Средство, обладающее апоптоз-индуцирующей активностью |
| KR102432499B1 (ko) * | 2018-04-20 | 2022-08-12 | 나이키 이노베이트 씨.브이. | 플레이트들 및 개재된 유체 충전 블래더를 구비하는 솔 구조체 및 제조 방법 |
| CN110128290B (zh) * | 2019-05-10 | 2022-04-29 | 江苏耐雀生物工程技术有限公司 | 红倍酚苯甲酰肼衍生物、中间体、制备方法及其应用 |
| CA3155694A1 (en) * | 2019-09-24 | 2021-04-01 | Genetec Inc. | Intermediary device for daisy chain and tree configuration in hybrid data/power connection |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4559157A (en) | 1983-04-21 | 1985-12-17 | Creative Products Resource Associates, Ltd. | Cosmetic applicator useful for skin moisturizing |
| LU84979A1 (fr) | 1983-08-30 | 1985-04-24 | Oreal | Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux |
| US4820508A (en) | 1987-06-23 | 1989-04-11 | Neutrogena Corporation | Skin protective composition |
| US4992478A (en) | 1988-04-04 | 1991-02-12 | Warner-Lambert Company | Antiinflammatory skin moisturizing composition and method of preparing same |
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| US5385936A (en) * | 1990-07-12 | 1995-01-31 | The United States Of America As Represented By The Secretary Of The Department Of The Health And Human Services | Gossypol acetic acid for the treatment of cancer |
| US5804567A (en) * | 1996-07-18 | 1998-09-08 | Cancer Institute (Hospital), Chinese Academy Of Medical Sciences | Method of increasing the effectiveness of anti-metabolites |
| JPH1036260A (ja) * | 1996-07-18 | 1998-02-10 | Mitsui Norin Kk | 抗ガン剤の効力増強方法 |
| US6428818B1 (en) | 1999-03-30 | 2002-08-06 | Purdue Research Foundation | Tea catechin formulations and processes for making same |
| WO2002047673A2 (en) * | 2000-12-15 | 2002-06-20 | Wackvom Limited | Methods and compositions to treat conditions associated with neovascularization |
| US7432304B2 (en) * | 2001-05-30 | 2008-10-07 | The Regents Of The University Of Michigan | Small molecule antagonists of Bcl-2 family proteins |
| AU2002305769B2 (en) * | 2001-05-30 | 2007-07-19 | Georgetown University | Small molecule antagonists of Bcl2 family proteins |
| DE602004012279T3 (de) * | 2003-06-25 | 2010-07-15 | The Burnham Institute, La Jolla | Katecholderivate zur behandlung von krebs |
-
2004
- 2004-06-25 DE DE602004012279T patent/DE602004012279T3/de not_active Expired - Lifetime
- 2004-06-25 CA CA2529507A patent/CA2529507C/en not_active Expired - Fee Related
- 2004-06-25 ES ES08003839T patent/ES2351581T3/es not_active Expired - Lifetime
- 2004-06-25 EP EP08003839A patent/EP1938816B1/en not_active Expired - Lifetime
- 2004-06-25 AT AT08003839T patent/ATE478663T1/de not_active IP Right Cessation
- 2004-06-25 SI SI200430628T patent/SI1653943T1/sl unknown
- 2004-06-25 PL PL04777151T patent/PL1653943T6/pl unknown
- 2004-06-25 US US10/877,781 patent/US7812058B2/en not_active Expired - Fee Related
- 2004-06-25 PT PT04777151T patent/PT1653943E/pt unknown
- 2004-06-25 EP EP04777151A patent/EP1653943B3/en not_active Expired - Lifetime
- 2004-06-25 DE DE602004028880T patent/DE602004028880D1/de not_active Expired - Lifetime
- 2004-06-25 AU AU2004258867A patent/AU2004258867B2/en not_active Ceased
- 2004-06-25 JP JP2006517702A patent/JP2007524633A/ja active Pending
- 2004-06-25 DK DK04777151T patent/DK1653943T4/da active
- 2004-06-25 AT AT04777151T patent/ATE387911T1/de not_active IP Right Cessation
- 2004-06-25 WO PCT/US2004/020569 patent/WO2005009434A2/en not_active Ceased
- 2004-06-25 ES ES04777151T patent/ES2303096T7/es active Active
-
2010
- 2010-10-07 US US12/900,319 patent/US8367644B2/en not_active Expired - Fee Related
-
2011
- 2011-09-29 JP JP2011215077A patent/JP2012025767A/ja active Pending
- 2011-12-19 US US13/329,611 patent/US20120269901A1/en not_active Abandoned